Phylogenetic conservation of protein–lipid motifs in pentameric ligand-gated ion channels  by Barrantes, Francisco J.
Biochimica et Biophysica Acta 1848 (2015) 1796–1805
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemPhylogenetic conservation of protein–lipid motifs in pentameric
ligand-gated ion channels☆Francisco J. Barrantes
Laboratory of Molecular Neurobiology, Institute for Biomedical Research (BIOMED), Faculty of Medical Sciences, UCA–CONICET, Av. Alicia Moreau de Justo 1600, C1107AFF Buenos Aires, ArgentinaAbbreviations:αBTX,α-bungarotoxin; nAChR, nicotin
pentameric ligand-gated ion channels
☆ This article is part of a Special Issue entitled: Lipid–pr
E-mail address: rtfjb1@yahoo.com.
http://dx.doi.org/10.1016/j.bbamem.2015.03.028
0005-2736/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 26 January 2015
Received in revised form 20 March 2015
Accepted 25 March 2015
Available online 31 March 2015
Keywords:
Acetylcholine receptor
Pentameric ligand-gated ion channels
Lipid–protein interactions
Bacterial ion channels
Cholesterol
Bacterial homologues
Synaptic receptorsUsing the crosstalk between the nicotinic acetylcholine receptor (nAChR) and its lipid microenvironment as a
paradigm, this short overviewanalyzes the occurrence of structuralmotifswhich appear not only to be conserved
within the nAChR family and contemporary eukaryotic members of the pentameric ligand-gated ion channel
(pLGIC) superfamily, but also extend to prokaryotic homologues found in bacteria. The evolutionarily conserved
design ismanifested in: 1) the concentric three-ring architecture of the transmembrane region, 2) the occurrence
in this region of distinct lipid consensusmotifs in prokaryotic and eukaryotic pLGIC and 3) the key participation of
the outer TM4 ring in conveying the inﬂuence of the lipid membrane environment to themiddle TM1–TM3 ring
and this, in turn, to the inner TM2 channel-lining ring, which determines the ion selectivity of the channel. The
preservation of these constant structural–functional features throughout such a long phylogenetic span likely
points to the successful gain-of-function conferred by their early acquisition. This article is part of a Special
Issue entitled: Lipid–protein interactions.
© 2015 Elsevier B.V. All rights reserved.“Three Rings for the Elven-Kings under the sky….
…One Ring to rule them all,
One Ring to ﬁnd them,
One Ring to bring them all….”
The Lord of the Rings, J.R.R. Tolkien
1. 4,000 million year-proof architectural design of pentameric
ligand-gated ion channels
Nicotinic acetylcholine receptors (nAChR) are members of the su-
perfamily of ligand-gated ion channels (pLGIC), a collection of neuro-
transmitter receptors which also includes γ-aminobutyric acid type A
or C (GABAA/C) receptors, glycine receptors, the subtype 3 of the seroto-
nin (5-HT3) receptors and glutamate-gated chloride channels (GluCl)
(see reviews in [1–3]). From a functional point of view, members
of the superfamily can be divided into two distinct types: the cation-
selective channels such as the nAChR and 5-HT3 receptor, and the
anion-selective channels such as the glycine and the GABAA and
GABAC receptors and invertebrate GluCl. Furthermore, these functional-
ly distinct classes of ion channels employ their unique combination ofic acetylcholine receptor; pLGIC,
otein interactions.ionic selectivity and cellular/tissue/species distribution to mediate
and/or modulate either excitatory or inhibitory chemical transmission.
The amino-terminal of all their subunits contains extracellular halves
of a pair of disulﬁde-bonded cysteines separated by only 13 residues,
the so-called Cys-loop, and thismotif has served for almost two decades
as a common identiﬁer to encompass the various receptor families pres-
ent in Metazoa, comprising the superfamily of LGIC coded in eukaryotic
genes. But more recently the ﬁnding of prokaryotic structural homo-
logues of the eukaryotic pLGIC [4–8] reviewed in [1,3,9–11] has added
a new twist, since although these bacterial channels do not possess a
Cys-loop and their sequence identity with other members of the LGIC
is rather low, the 3-D structural similarity with the eukaryotic LGIC is
so remarkable that it appears more convenient to group all these pro-
teins together under the common denomination of pentameric LGIC
(pLGIC). Dysfunction of pLGICs plays an important role in several disor-
ders of the central nervous system, including Alzheimer's disease [12],
schizophrenia [13], Parkinson's disease [14] and other pathologies. As
recently reviewed [1] pLGICs constitute targets for an ever increasing
variety of pharmacological and clinically important drugs, including
general anesthetics, smoking cessation aids, anxiolytics, anticonvul-
sants, muscle relaxants, hypnotics, behavior and mood-modifying
substances, anti-emetics, and a variety of drugs used in the treatment
of epilepsy, insomnia, panic disorders, and other neurological and
neuropsychiatric conditions. Some of these drugs activate responses, act-
ing as agonists; others block the ortholog or the allosteric sites, and an
ample spectrum of other drugs modulate -potentiating or decreasing-
the amplitude of the responses.
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the electric organ of electric ﬁsh [15] and the availability of the compet-
itive cholinergic antagonist α-bungarotoxin from the snake Bungarus
multicinctus [15,16] were the two key elements that led to the isolation,
biochemical puriﬁcation, pharmacological and functional characteriza-
tion of the nAChR, a saga which started more than forty years ago
[17]. Muscle-type AChRs are expressed in the peripheral nervous sys-
tem and neuronal-type AChRs in both peripheral and central nervous
systems as well as in other non-neural cells such as immune cells, lym-
phocytes, lung epithelium and others. In brain, the nAChR is present in
two principal forms: the heteropentameric receptor formed by α4 and
β2 subunits and the homopentameric receptor formed exclusively by
α7 subunits [11,18]. The nAChR rapidly became the reference neuro-
transmitter receptor, and continues to be the prototype for the pLGIC
superfamily. The 30-year-improvement in the electron microscopy res-
olution of the Torpedo nAChR structure, currently at about 4 Ångstrom
resolution [19–24] and the crystal structure of the water-soluble homo-
logue of the nAChR extracellular domain (the molluscan ACh-binding
protein, AChBP) by X-ray diffraction techniques [25,26], were also ﬁrst
hits in the structural characterization of neurotransmitter receptors
and structural homologues, and have had an important impact on our
knowledge of pLGIC structure. A recent appearance on the scene is the
X-ray crystal structure of various complexes between pLGIC and phar-
macologically relevant drugs or endogenous ligands such as the com-
petitive antagonist α-bungarotoxin bound to the extracellular domain
of the nAChRα subunit at 1.94 Å resolution [27]; the ligand-binding do-
main of a nAChR chimera in complex with agonist [28]; and acetylcho-
line (the endogenous neurotransmitter of the nAChR), which acts as a
competitive antagonist when bound to an aromatic cage in the extracel-
lular domain of the bacterial protein ELIC, at 2.9 Å resolution [29]. New
crystal structures have followed: themouse 5-HT3 receptor at 3.5 Å res-
olution [30], the ﬁrst eukaryotic anionic-gated channel (from theworm
Caenorhabditis elegans) in the apo-state and in complex with the anti-
parasitic drug Ivermectin [31], the bacterial ELIC channel in the presence
of memantine, a drug used in the amelioration of cognitive deﬁcits
in Alzheimer's patients [32]; the 2.99 Å resolution X-ray structure of
GLIC bound with the general anaesthetic ketamine, revealing an inter-
subunit cavity that partially overlaps with the homologous antagonist-Fig. 1. Location of the three rings in the transmembrane region of the pentameric ligand-gated ion c
(right) are arranged in three concentric rings, probably the structural feature best conserved in
subunit is shown in the case of the nAChR, and two subunits (gray and blue) in the case of GLIC. D
to be endogenous lipids tightly bound to the protein. The ﬁgure on the left has been modiﬁedbinding site in eukaryotic pLGICs [33], and the human GABAA receptor
[34]. These and other recent structural ﬁndings and analyses of pLGIC
[3,9,35] have provided a much-needed architectural framework to
better understand and in some cases reformulate several important
mechanistic aspects of ligand binding, gating and blockage of pLGIC
macromolecules from an entirely new perspective.2. A phylogenetically conserved architecture of the pLGIC: the trans-
membrane “three-rings” design
Classically, various topographical regions have been distinguished in
the nAChRmacromolecule: an extracellular domain exposed to the syn-
aptic gap, a transmembrane (TM) region composed of 20 hydrophobic
segments having 20–30 amino acids each, and the cytoplasmic domain
made up of loops linking the TM segments. Most relevant to the topic of
this review is, of course, the 3-ring cylinder of concentrically arranged
TM1–TM4 segments [36]. As shown in Fig. 1, the inner ring is made of
ﬁve TM2 helices, one from each subunit, which constitutes the walls
of the ion channel proper [37–39], devoid of contact with the mem-
brane lipid. The inner ring is the site of the selectivity ﬁlter, the region
of the nAChR determining which ions permeate the pore and which
do not. The selectivity ﬁlter consists of rings of amino acid residues
pointing towards the ion channel central pore, in the lower portion
(i.e. the cytoplasmic end of the TM2 segment) [40–42]. The middle
ring is formed by ten helices, the TM1 and TM3 segments, which estab-
lish a substantial physical contact withmembrane lipids. The outermost
ring, made up of ﬁve TM4s, is totally embedded in the lipid bilayer. I
have proposed that the middle and outer rings constitute an important
domain deﬁned by the extensive interface between the protein and
lipid moieties, comprising both the lipid-exposed TM portions of the
nAChR protein and the nAChR-vicinal lipid, respectively [36,43]. The
latter corresponds to the lipid-exposed belt (“shell” “annular”, “bound-
ary”, “nAChR vicinal”) region [44–47], that is, the lipidmoiety in the im-
mediate perimeter, including crevices, of the nAChR protein, earlier
discovered by Marsh and myself using electron spin resonance (ESR)
techniques [44] and further characterized in terms of lipid selectivity
and stoichiometry [48–52]. As we will see in this review, sites forhannels. The 20 chains in the eukaryotic nAChR (left) and in the bacterial homologue GLIC
pLGIC for about 4000Ma of channel evolution. Only the helix bundle corresponding to one
etergent (DDM) and lipid (LIP)molecules co-crystallizewith GLIC. The lipids are assumed
from Unwin and coworkers [179,180] and the right illustration is taken from Ref. [4].
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come a common ﬁnding in this interface domain.
The structural similitudes among pLGIC are not restricted to the
TM region [1,53]. For instance, Dellisanti et al. [54] have analytically
compared the packing of the extracellular domain of some prokaryotic
and eukaryotic pLGIC, arguing that loose packing of cavities in eukaryot-
ic pLGIC hydrophobic cores likely developed as an evolutionary strategy
aimed at facilitating the allosteric transitions required for rapid ligand-
induced switching between closed and open channel states. Although
the chemical makeup of the signals that activate or antagonize their
action may differ, it is not totally unforeseen that members of the
eukaryotic superfamily of pLGIC implement common structural designs
in their extracellularmoiety and in their TM region. The 3-ring architec-
ture, conserved in eukaryotic nAChRs, GABAA, GABAC, GluCl and 5-HT3
receptors, is a vivid example; however, when we observed an identical
design in the bacterial homologues GLIC and ELIC [55], the ﬁnding came
as a total surprise. The stability of the design over an evolutionary period
of more than 4000Ma is also quite remarkable, and probably amanifes-
tation of the success of its early adoption and conserved maintenance.
3. The key contribution of the outer TM4 ring: lipid sensing function
In 2005weundertookmolecular dynamic studies of the entire trans-
membrane region (180,000 atoms) of the nAChR in a lipid bilayer,
with the aim of understanding the mechanics of gating kinetics [56].
However, what was probably the most relevant (and unexpected) out-
come of the work was the ﬁnding that the TM4 outer ring underwent
substantialmotions in the timewindow explored, changing extensively
its contacts, in an alternating fashion, with the lipid surrounding its out-
side boundaries orwith themiddle ring (TM1–TM3) helix bundle inside
its perimeter, respectively. From this modelling exercise we explicitly
suggested that “the outer ring of TM4 acts as the vehicle to transfer the
inﬂuences of the lipid surroundings to the conformational changes of the
whole channel” [56]. We further elaborated that this ability of the TM4
ring provided a rationale for the effect of mutations in αTM4, βM4,
and γTM4 on channel function, and for the inﬂuence of the lipid envi-
ronment on the stability of nAChR functional states, as well as on how
several pharmacologically relevant ligands that partition in the lipid
bilayer affect nAChR channel function [56,57]. Strong support for the
lipid sensing role of TM4 stemming from our molecular modeling and
ﬂuorescence studies was provided by the electrophysiological studies
of Auerbach and coworkers (e.g. [58]) indicating that TM4 undergoes
substantial motion in the course of nAChR gating.
Mutations of amino acid residues at the lipid–protein interface of
Torpedo and muscle-type nAChRs provided additional experimental
evidence for the functional coupling of the outer TM4 ring with the rel-
atively distant ion permeation pathway lined by the inner ring of TM2s,
secluded from contact with the lipids by the middle TM1–TM3 ring.
Most mutations modify the kinetics of channel gating by altering the
rate of the transitions between channel states, some of them to an
extent that mimics pathological conditions akin to congenital myas-
thenic syndromes [59–61].
Baenziger and colleagues have signiﬁcantly contributed to thedevel-
opment and extension of the concept of TM4 acting as a lipid sensor [53,
62–67], especially by disclosing the functional implications of the termi-
nal region of TM4 located outside the lipid bilayer and therefore termed
“post-M4”. This group highlights the role of Gln435, located in the post-
M4 extracellular region, and purported to interact with Phe137, located
in the extracellular Cys-loop [62]. In this hypothesis, Gln435 and Phe137
would couple the extracellular domain with the transmembrane do-
main, and thus functionally couple agonist bindingwith channel gating.
Baenziger's idea is that post-M4 interaction with the extracellular
Cys-loop would also be subject to lipid modulation, and that ineffective
coupling leads to a non-functional, “uncoupled” state of the channel
(see below). Early mutagenesis studies which deleted residues or
truncated part of TM4, thus effectively shortening its length, wereinitially invoked to claim lack of inﬂuence of TM4 on nAChR channel
function [68], an assertion which is currently invalidated by the wealth
of information on mutagenesis of TM4 residues and their effect on ion
permeation function. The functional implications of the TM4 trunca-
tion/deletion studies of nAChR can thus be reinterpreted in the light/
in support of the Baenziger hypothesis of agonist binding with channel
activity via coupling of post-M4 with the extracellular domain [53,62,
64,65,67].
The phylogenetically conserved structure of the TM4 lipid-sensing
region in prokaryotic and eukaryotic ion channels points to the inherent
functional correlates; mutations in the TM region of the eukaryotic pro-
teins which provoke changes in the ion permeation properties [69–79]
ought to be observed when tinkering with the bacterial TM regions.
This appears to be the case. Deletion of aromatic residues at the inter-
face region between TM4 and the TM1–TM3 bundle in GLIC reduces
the interaction between the two rings [80], affecting the normal assem-
bly of the pentamer. The alteration in the assembly of the mature oligo-
mer following tinkering of the aromatic residues in the TM segments is
also observed in other members of the pLGIC, such as the glycine recep-
tor, leading to the more general conclusion that the geometry of
the TM1–TM4 tetrahelical packing is important for the nascent pLGIC
subunits to adopt a closed ﬁve-fold symmetry [81]. Furthermore, muta-
tions in the TM4 region of ELIC and GLIC which alter the interactions
of the TM4 lipid sensing domain with the TM1–TM3 helix bundle indi-
cate that aromatic residues strengthen the interactions between
the two rings and hence reduce the crosstalk of TM4 with the lipid mi-
croenvironment [66]. These data provide full support to the molecular
dynamics data and interpretation of these data in terms of alternating
crosstalks of TM4 with its surrounding lipids outside or the TM1–TM3
bundle inside, which gave rise to the lipid sensing hypothesis [56].
4. The physical state of the nAChR lipid microenvironment
In absolute terms, lipid molecules in a biomembrane outnumber
those of protein molecules, and the physical properties of the mem-
brane derive predominantly from the physical state of the lipid milieu.
The pioneering study of Epstein and Racker [82] on the reconstitution
of puriﬁed nAChR set the basis for exploring the chemical composition
and physical state of the host lipidswith a view to understanding the in-
ﬂuence of the latter on receptor function upon puriﬁcation and reconsti-
tution and, by extrapolation, in the native membrane environment.
Contemporary with these attempts, the phase state of lipid bilayers in
general was being characterized using a variety of physicochemical
and biophysical approaches, and it is thus natural that the bulk physical
properties of the lipid became an area of research in the receptor ﬁeld.
Model membrane studies showed that cholesterol–phospholipid mix-
tures at high cholesterol concentrations mimicked many aspects of the
phase state displayed by biological membranes rich in cholesterol.
These mixtures lack a deﬁned lipid phase transition and instead are
characterized by a single phase state, the liquid-ordered (Lo) phase
[83], with properties between the gel and the ﬂuid lipid phases. For
low cholesterol concentrations, solid-ordered (So) or liquid-disordered
(Ld) phases are observed, depending on whether the system is above
or below its gel–ﬂuid transition temperature (Tm), respectively. When
the binary lipid system is at intermediate cholesterol concentrations,
there is phase coexistence of So and Lo (below) or Ld and Lo (above),
depending on the temperature relative to Tm.
Early studies exploring lipid effects on nAChR focused on the inﬂu-
ence of lipid composition on the ion permeation properties and the con-
formational equilibria of the receptor protein reconstituted in deﬁned
lipid mixtures [84–86]. The capacity of reconstituted AChR to translo-
cate ions in vitro was found to be sensitive to the bulk physical proper-
ties of the host membrane, such as its “ﬂuidity” [86–89], and this in turn
was found to be sensitive to the chemical composition and cholesterol
content of the hostmembrane [84,86,90–92]. The inﬂuence of phospha-
tidylethanolamines [93], phosphatidylserine [94] and phosphatidic acid
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the nAChR protein on the physical state of phosphatidic acid-containing
membranes [96]. The effect of phospholipid/sterol composition and
length and saturation of the phosphoglyceride acyl chains on the con-
formational states of the nAChR were also the subject of study [62,65,
93,98–105]. Acyl chain length determines lipid bilayer thickness, and
this physical property inﬂuences the orientation of the hydrophobic
TM segments of the nAChR [57]. A recent outcome of this series of stud-
ies bears on the identiﬁcation of the functionally “uncoupled” receptor
conformation (daCosta et al., 2009 and see below). Phosphatidylcho-
lines lack speciﬁcity for the nAChR [44,52,106] and nAChR reconstituted
in phosphatidylcholine membranes lacking “activating” lipids is stabi-
lized in the uncoupled conformation, from which it can slowly emerge
upon ligand binding and transit to the desensitized conformation if
the host membrane is thick enough, e.g. with di22:1 acyl chains [64].
Electron-spin resonance (ESR) studies [50–52,107–110] made
apparent the occurrence of two distinct signals in ESR experiments
with native and reconstitutedmembranes containingnAChR at relative-
ly high or low concentrations: one signal corresponded to the bulk
membrane lipid and the other was interpreted as stemming from the
protein-immobilized lipid. These direct interactions between protein
and lipid moieties were observed with fatty acids, phospholipids, and
sterols in the native membrane environment. Ellena et al. [109]
conﬁrmed our ﬁndings using reconstituted nAChR. Rousselet et al.
[110,111] found immobilization with fatty acids but not with phospho-
lipids. The Lo nature of the nAChR immediate perimeter was further
conﬁrmed in native membranes using ﬂuorescence [112] or a combina-
tion of ﬂuorescence and single-channel patch-clamp recordings [113].
This series of studies from different laboratories demonstrated
that shell nAChR protein-vicinal lipids are relatively immobile with re-
spect to the rest of the membrane lipids and pointed to the existence
of phase lateral heterogeneity in membrane lipids much earlier than
the concept of “rafts” came into use.
The lipid “raft” hypothesis proposes that a subset of speciﬁc lipid
species self-associates to form microdomains or platforms that can
intervene in protein partition, signaling and other functional
properties [114–118]. Early studies on the nAChR proposed the exis-
tence of two cholesterol pools in nAChR-rich membranes from Torpedo:
an easily extractable fraction that inﬂuences the bulk ﬂuidity of the
membrane and a tightly bound receptor-associated fraction [119]. Evi-
dence has become available indicating that nAChRs interact with
cholesterol-rich lipid domains in vitro and in vivo [120–125]. In our lab-
oratory it has also been demonstrated that cholesterol plays a key role in
the trafﬁcking of the nAChR along the early secretory [126] and
endocytic [127] pathways and also affects nAChR distribution in the
plasma membrane [127,128].
The structural requirements for steroid stabilization or disruption of
lipid domains containing nAChRwere systematically investigated using
ﬂuorescence techniques [129] and more recently the puriﬁed and
reconstituted nAChRwas found to partition into roughly similar propor-
tions between Lo and Ld domains [130]. In living cells, the distribution of
nAChR diffraction-limited (nano)-clusters at the cell surface appears to
follow the same trend, and changes in the cholesterol content modify
the proportion of nAChR sub-resolution clusters associated with either
Lo or Ld domains [131].
5. Functional effects of cholesterol and steroid on nAChR
The term pLGIC alludes to the two functional properties of this
superfamily of receptors/ion channels: 1) ligand binding and 2) ion per-
meation. Cholesterol and other sterols, and various types of steroids
affect both the ligand recognition ability and the ion channel functions
of these proteins. Cholesterol and water-soluble analogues modify
the equilibrium between the agonist-dependent functional states of
the nAChR [86,132–136]. Chol depletion increased the probability of
channel opening and the duration of the channel by ~30% alreadyafter 15 min. By contrast, Chol enrichment resulted in an ~33% diminu-
tion in the channel mean open time [127]. Since Chol depletion acceler-
ates endocytosis and thus reduces the amount of nAChR at the cell
surface [127,137], the changes in channel kinetics (increased open
dwell time) may represent a transient compensatory mechanism to
maintain AChR function until new receptors are targeted to the cell sur-
face.Whether these interactions are direct or indirect has been amatter
of debate (see reviews in [47,138]). Whereas indirect interactions de-
pend on changes in the free energy difference between diverse protein
conformational states, apply to membrane proteins in general and are
allosteric in nature, direct interactions imply the binding of cholesterol
to the protein, sometimes in a stereospeciﬁc mode [139]. Where this
binding occurs, the exact stoichiometry and the precise nature of the in-
teractions of cholesterol with the nAChR are still not fully elucidated,
nor are the mechanisms by which these interactions are ﬁnally trans-
duced into the observed epiphenomenological changes in the receptor's
ligand binding, i.e. ion permeation.
The effects of steroids have been characterized in detail on
two “cousin” members of the pLGIC superfamily: central nervous sys-
tem GABAA receptors [140,141] and both muscle-type and neuronal-
type nAChRs [50,142–154]. In the central nervous system neurosteroids
modulate GABAA receptors producing sedation, anasthesia, anti-anxiety
and anticonvulsive effects. In the case of the neuronal nAChR, steroids,
and neurosteroids in particular, also affect nAChRs. The neurosteroid
17β-estradiol potentiates α4β2 nAChRs, but not rat α4β2 nAChRs
[150,151]. Glucocorticoids are also modulators of nAChR channel
function, and an allosteric mechanism was proposed to account for
the mechanism of action of these ligands [144]. Using an alanine-
substituted quadruple mutant of four putative lipid-exposed residues
in TM4 (Leu411, Met415, Cys418 and Thr422) Garbus et al. [153] dis-
sected the effect of hydrocortisone into four Ala-substituted receptors,
and found that the Thr422, a residue located close to the extracellular-
facing membrane hemilayer in the α-subunit TM4, had direct bearing
on the inhibition exerted by hydrocortisone on the receptor. It is inter-
esting to note that the interface between theα and β subunits in the TM
domain of the GABAAR, in the same region as the Ivermectin site in the
nematode GluCl protein, has been identiﬁed through mutagenesis
as the probable site of action of allopregnanolone and THDOC, two
neurosteroids that display positive allosteric modulatory effects [155].
6. The “uncoupled” nAChR conformation
Baenzinger and coworkers have extensively studied the conforma-
tional equilibria of the nAChR and the inﬂuence of lipids on nAChR
state transitions [104]. This group has discovered that Torpedo nAChR
reconstituted into phosphatidylcholine membranes lacking cholesterol
and anionic lipids adopts a conformation in which agonist binding is
uncoupled from channel gating [62], reviewed in [64]. These authors
have also systematically explored the contributions of anionic lipids
like phosphatidic acid to this phenomenon [63,65,94,95] and in particu-
lar the mechanism for re-activating uncoupled nAChRs back to their
functional state, with interesting biomedical implications [65]. Hénault
et al. [67] and Mowrey and coworkers [35] have recently reviewed the
structural studies on the bacterial homologue ELIC, the crystal structure
ofwhich exhibitsmany of the properties purported to correspond to the
uncoupled conformation, as supported by electrophysiological data
[156]. Further insight into the “uncoupled conformation” of the nAChR
and its functional implications can be found in another review of this
series (Ref. Baenziger et al., 2015).
7. The search for cholesterol sites on the nAChR and pLGIC
The three-ring TM region of the pLGIC is the site of action of a variety
of chemical substances, including the endogenous lipids present at the
host membrane –essentially phosphoglycerides and cholesterol, and
exogenous compounds of pharmacological interest, ranging from anti-
Fig. 2. A cholesterol molecule docked on the surface of the CARC cholesterol recognition
domain [163,169] in the TM4 of the Torpedo nAChR α-subunit. The polypeptide chain is
shown in line/ribbon representation except for the area in theproximity of the bound cho-
lesterol, which is displayed in surface-rendering mode. The lipid is shown in CPK
rendering.
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within the category of positive allosteric modulators and in the case of
the nAChR, and the neuronalα7 subtype in particular, thesemodulators
comprise PNU-120596, TQS, and various other chemically diverse com-
pounds purported to bind to sites at the TM domain and slow down
the rate of desensitization at themolecular level, while having cognitive
enhancing effects on brain function [12]. The search for site(s) and
mechanism(s) of action of cholesterol on thenAChRand othermembers
of the pLGIC has made the researchers interested in the ﬁeld for quite
some time [45,86,92,136,145,146,149,157–166]. Electron–spin reso-
nance, ﬂuorescence quenching and reconstitution of puriﬁed nAChR
have provided useful information on this topic. Photoafﬁnity labelling
techniques have been the experimental approach of choice in the search
for cholesterol binding sites on the nAChR protein. Early experiments
were targeted at the characterization of labelling to the intact subunits
[145,157] and/or employed photoactivatable sterols that were purported
to be functional cholesterol analogues [149,166]. More recent
photoafﬁnity labelling studies conﬁrmed earlier results and led to the
identiﬁcation of putative cholesterol-nAChR interaction sites at the
TM4, TM3, and TM1 segments of each subunit, fully overlapping the
lipid–protein interface of the nAChR [159]. The TM4 segment showed
the most extensive interaction with the cholesterol analogues. For
αTM4, the labelling pattern was consistent with the incorporation of an
azido derivative of cholesterol into αGlu-398, αAsp-407, and αCys-412,
i.e. amino acid residues that lie in a rather shallow region in the NH-
term of the αTM4 transmembrane segment. Using ﬂuorescence
quenching techniques, sterol sites were also identiﬁed in all TM regions
of native nAChRs, and their depth in the membrane bilayer could also
be established [167].
The search for cholesterol sites on the nAChR has also relied on in-
silico approaches. Molecular dynamics simulations of the nAChR in the
presence or absence of cholesterol led Brannigan et al. [168] to conclude
that the nAChR possesses multiple cholesterol binding sites, some of
which correspond to non-annular cavities located between the nAChR
transmembrane α-helices, deeply buried in the protein, and that the
nAChR collapses in the absence of the sterol. Their argument is based
on the observation of “holes” in the electron density maps of the
nAChR cryoelectron microscopy images of Unwin [21], which could ac-
commodate up to 15 cholesterol molecules. From ESR experiments
[106]we calculated that the outer perimeter of the nAChR could accom-
modate up to 15 cholesterol molecules which readily exchanged with
bulk lipids in these experiments; this would not occur in the case of
the deeply buried cholesterols postulated from in-silico calculations.
More recent works from our laboratory resulted in the identiﬁcation
of cholesterol recognition motifs in the TM region not only of the
nAChR and other members of the pLGIC, but also conspicuously present
in other transmembrane proteins such as the GPCR superfamily [163,
169] (Fig. 2).
Cholesterol sites have been recently identiﬁed at the TM surface of
the human GABAAR based on the structure of the glutamate-gated
GluCl of C. elegans [162] using a combination of several molecular
modelling approaches, one of them based on the analogy with the Iver-
mectin molecule docked on GluCl crystals [170].
8. Presence of lipid and general anaesthetic sites in the bacterial
homologues of pLGIC
The cyanobacterium Gloeobacter violaceous does not possess choles-
terol. However, the X-ray studies of Nury et al. [8,171] on the nAChR
prokaryotic homologue GLIC have revealed that binding of general an-
aesthetics occurs at a site located at the protein–lipid interface where
nearby ordered lipids were previously identiﬁed [4,5,172] (see Fig. 1).
One of the lipid molecules lies in a crevice between TM1 and TM4;
this lipid is observed in two of the structures (apo and des-ﬂurane)
but is displaced in the structure when the general anaesthetic propofol
is bound to GLIC. General anaesthetics such as propofol and desﬂuraneare known to be positive allosteric modulators of GABAA receptors
in eukaryotic pLGIC [10] and exert the opposite action, i.e. negative allo-
steric modulation, on prokaryotic GLIC [173]. The lipids identiﬁed in the
crystal structure were not exogenous lipids added in the course of puri-
ﬁcation/crystallization, and were therefore interpreted as endogenous
lipids present in the nativemembranewhere GLIC is inserted, indicating
a tight binding between the protein and lipid moieties [4]. It has also
been suggested that the alteration of GLIC–lipid interactions caused by
binding of the general anaesthetic molecule might contribute to
functional inhibition [171]. In the case of the eukaryotic GluCl from
C. elegans, phospholipid molecules have recently been identiﬁed in the
crystal structure, as shown in Figs. 3 and 4. The phospholipids compete
with the drug Ivermectin and potentiate glutamate binding to the GluCl
channel. The binding site is located between TM1 and TM3helices of ad-
jacent subunits, with the phosphocholine head group pointing towards
the center of the pore and the two alkyl tails at the periphery of the
transmembrane domain [31]. In the prokaryotic organism ELIC general
anaesthetics bind more promiscuously to three different types of sites.
The binding site located at the ion channel proper (the pore site, “PS”
in Fig. 5) is presumably responsible for the non-competitive type of
blockage that general anaesthetics exert on ELIC and other ion channels
[174]. A second site, (“TS”) is present at the TM region (Fig. 5), in a crev-
ice formed at the interface between two subunits. Thewalls of the crev-
ice are formed by the middle (TM1) and outer (TM4) rings of one
subunit and the middle ring (TM3) of another subunit. General anaes-
thetics may thus compete with endogenous lipids in the case of GLIC
or ELIC, but also possibly with cholesterol [43] and/or neurosteroids
[155,175] in the case of eukaryotic pLGICs such as the nAChR or
Fig. 3. Recent crystallographic studies of Gouaux and his group [31] have established the atomic position of phosphatidylcholine (POPC) in the pentameric GluCl channel of the nematode
C. elegans: The head group of one of the POPCmolecules (yellow ball) is shownwedgedbetween the TM1 and TM3 transmembrane helices, that is in themiddle ringmotif [36] common to
all pLGIC (from [31]).
1801F.J. Barrantes / Biochimica et Biophysica Acta 1848 (2015) 1796–1805GABAA receptors (see previous sections). It is interesting to note that
general anaesthetics exert the same type of pharmacological effect on
GLIC and nAChRs: both are inhibitory (see review by [10]. By contrast,
glycine and GABAA receptors are mostly potentiated by general anaes-
thetics. Using MD simulations, Nury et al. [171] also showed changes
in the lipid cavities caused by motions of TM2 and TM3, suggesting
that the shape and volume of the cavity are coupled to channel gating.
The observation of changes in the shape of the lipid cavities in GLIC
upon binding of the general anaesthetic propofol was also reported re-
cently by Gosh et al. [176], who challenge the recent crystallographic
data of Nury et al. [171], maintaining that in the resting state propofol
does not bind in the TM domain intrasubunit cavity as observed in the
crystal structure of GLIC with bound propofol.Fig. 4. Location of the phospholipid POPC at one of the inter-subunit sites in GluCl. Phospholipids com
channel of the nematode C. elegans. a and b, POPC binding site between TM1and TM3 helices of
of the pore in (b) is shown by a gray circle and the overlap between the phospholipid and Iverm
the center of the pore and the two alkyl tails are located at the periphery of the transmembran9. Perspectives and future developments in the ﬁeld
During the last few decades experimental evidence has pro-
vided a solid foundation to the assertion that the most important
consequence of the cross-talk between the membrane lipid environ-
ment and the nAChR is the functional modulation exerted by lipids
on the protein. nAChR functional properties affected by the mem-
brane surroundings encompass the processes of channel gating, the
kinetics of opening and closing of the channel proper, the kinetics
of desensitization, the supramolecular distribution and translational
dynamics of the protein at the cell surface (reviewed here and in [43,
177]). The availability of high resolution X-ray diffraction structures
of various representative members of the pLGIC in which thepetewith the antiparasitic drug Ivermectin and potentiate glutamate binding to theGluCl
adjacent subunits viewedparallel (a) and perpendicular (b) to themembrane. The location
ectin is displayed in ‘stick’ representation. The phosphocholine head group points towards
e domain. From Ref. [31].
Fig. 5. Transmembrane middle (TM1–TM3) and outer (TM4) rings of the bacterial homologue
ELIC provide binding sites not only for lipids but also for a variety of pharmacologically relevant
compounds, like general anaesthetics. Here the TMbinding site (“TS”) of a chloroformderiv-
ative (magenta) is formed at the interface between two subunits. The walls of the crevice
are formed by the middle (TM1) and outer (TM4) rings of one subunit (orange) and the
middle ring TM3 polypeptide chain of another subunit (blue) in the pentameric bacterial
homologue ELIC. An additional binding site (pore site, “PS”) for the general anaesthetic lies
within the ion channel, and is presumably responsible for the non-competitive type of
blockage. From Spurny et al. ([174]).
1802 F.J. Barrantes / Biochimica et Biophysica Acta 1848 (2015) 1796–1805presence of lipids, anaesthetics or pharmacologically important
compounds is apparent, as reviewed here, will likely continue to ex-
pand our comprehension of the detailed structure–function correla-
tions needed to understand the physiology and dysfunction of the
nAChR and other members of the pLGIC.
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